Targeted treatment in viral‐associated inflammatory cardiomyopathy

Detection of viruses like HHV‐6 in endomyocardial biopsy or serum serology of patients with myocarditis or heart failure features unresponsive to conventional heart failure therapies could be a potential targeted treatment especially in refractory cases.

Detalles Bibliográficos
Autores principales: Amin, Ahmad, Taghavi, Sepideh, Chenaghlou, Maryam, Zare, Elahe, Kamali, Monireh, Naderi, Nasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299269/
https://www.ncbi.nlm.nih.gov/pubmed/34322262
http://dx.doi.org/10.1002/ccr3.4518
_version_ 1783726236045934592
author Amin, Ahmad
Taghavi, Sepideh
Chenaghlou, Maryam
Zare, Elahe
Kamali, Monireh
Naderi, Nasim
author_facet Amin, Ahmad
Taghavi, Sepideh
Chenaghlou, Maryam
Zare, Elahe
Kamali, Monireh
Naderi, Nasim
author_sort Amin, Ahmad
collection PubMed
description Detection of viruses like HHV‐6 in endomyocardial biopsy or serum serology of patients with myocarditis or heart failure features unresponsive to conventional heart failure therapies could be a potential targeted treatment especially in refractory cases.
format Online
Article
Text
id pubmed-8299269
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82992692021-07-27 Targeted treatment in viral‐associated inflammatory cardiomyopathy Amin, Ahmad Taghavi, Sepideh Chenaghlou, Maryam Zare, Elahe Kamali, Monireh Naderi, Nasim Clin Case Rep Case Report Detection of viruses like HHV‐6 in endomyocardial biopsy or serum serology of patients with myocarditis or heart failure features unresponsive to conventional heart failure therapies could be a potential targeted treatment especially in refractory cases. John Wiley and Sons Inc. 2021-07-23 /pmc/articles/PMC8299269/ /pubmed/34322262 http://dx.doi.org/10.1002/ccr3.4518 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Amin, Ahmad
Taghavi, Sepideh
Chenaghlou, Maryam
Zare, Elahe
Kamali, Monireh
Naderi, Nasim
Targeted treatment in viral‐associated inflammatory cardiomyopathy
title Targeted treatment in viral‐associated inflammatory cardiomyopathy
title_full Targeted treatment in viral‐associated inflammatory cardiomyopathy
title_fullStr Targeted treatment in viral‐associated inflammatory cardiomyopathy
title_full_unstemmed Targeted treatment in viral‐associated inflammatory cardiomyopathy
title_short Targeted treatment in viral‐associated inflammatory cardiomyopathy
title_sort targeted treatment in viral‐associated inflammatory cardiomyopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299269/
https://www.ncbi.nlm.nih.gov/pubmed/34322262
http://dx.doi.org/10.1002/ccr3.4518
work_keys_str_mv AT aminahmad targetedtreatmentinviralassociatedinflammatorycardiomyopathy
AT taghavisepideh targetedtreatmentinviralassociatedinflammatorycardiomyopathy
AT chenaghloumaryam targetedtreatmentinviralassociatedinflammatorycardiomyopathy
AT zareelahe targetedtreatmentinviralassociatedinflammatorycardiomyopathy
AT kamalimonireh targetedtreatmentinviralassociatedinflammatorycardiomyopathy
AT naderinasim targetedtreatmentinviralassociatedinflammatorycardiomyopathy

Ejemplares similares